Venture Capital

Qiming Venture Partners

Qiming Venture Partners is a leading China-based venture capital firm founded in 2006 by Duane Kuang and Gary Rieschel, headquartered in Shanghai with additional offices in Beijing, Suzhou, Hong Kong, Singapore, and a U.S. affiliate (Qiming Venture Partners USA) in Seattle, Washington. The firm invests at the early and growth stages, with roughly 70% of its investments concentrated in Series A and Series B rounds, across two core practice areas: Technology (mobile internet, consumer, AI, robotics, semiconductors, enterprise software, autonomous driving) and Healthcare (biotech, pharmaceuticals, medical devices, diagnostics, and digital health). Qiming manages 11 U.S. Dollar funds and 7 RMB funds with approximately $9.5 billion in capital raised, and has backed more than 580 companies, of which over 210 have exited via IPO on the NYSE, NASDAQ, HKEX, Shanghai, or Shenzhen exchanges, or through M&A. It is an early backer of some of China's most influential technology companies, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, Insta360, and Zhipu AI (Z.ai), alongside a deep healthcare portfolio spanning Zai Lab, Gan & Lee Pharmaceuticals, CanSino Biologics, Tigermed, and Insilico Medicine.

374 portfolio companies 374 publish APIs here 13 properties
Venture CapitalSeedSeries ASeries BGrowth EquityTechnologyHealthcareArtificial IntelligenceSemiconductorsRoboticsBiotechChinaAsia
The Qiming Venture Partners API Portfolio cover
API Evangelist Portfolio Report
The Qiming Venture Partners API Portfolio

Every Qiming company that ships an API, scored the way a machine reads it — and why a competent China deep-tech book publishes APIs but has not yet operationalized trust.

Read the report $750.00 · every API-bearing company in the book, scored on the Kin Score
Portfolio Strength across 374 profiled portfolio companies on the network
1 top-rated API companies 0 exemplar · 1 strong
14 agent-ready companies 0 agent-native · 14 agent-ready
Average quality of the book:
Composite minimal 8.9
Agent-Readiness human-only 2.8

Firms are ranked by cumulative portfolio strength — how many highly-rated API companies they've backed, weighted by tier across composite quality and agent-readiness. The averages below are a secondary read on the typical company in the book.

Qiming Venture Partners has 374 portfolio companies tracked on the APIs.io network, of which 374 (100%) publish APIs indexed here.

Its highest-rated API providers on the network are xiaoman, StepFun, game, swap, infstones.

Portfolio on the Network

Portfolio companies that publish APIs indexed on APIs.io, grouped by their API Evangelist rating. Exemplar and Strong are expanded by default.

Strong 1 Solid coverage with minor gaps
Developing 6 Usable, with meaningful gaps to close
Thin 15 Limited public surface area
Emerging 23 Early or largely undocumented
Minimal 329 Almost no public developer surface
caimitech 12.9 Hesai Technology 12.9 1hai 12.7 crownbio 12.5 kingsware 12.3 hugemed 12.1 hyperz 11.8 infervision 11.8 abogenbio 11.6 apollomicsinc 11.6 asieris 11.6 frontagelab 11.6 origene 11.6 tigermed 11.6 Zai Lab 11.6 pratilipi 11.5 ethealthcare 11.2 Gan & Lee Pharmaceuticals 11.2 vongihealth 11.2 antengene 10.8 tutorabc 10.8 zgbiotech 10.8 zincfive 10.6 akulaku 10.5 apusapps 10.5 castboxapp 10.5 connectbiopharm 10.5 imile 10.5 ltztherapeutics 10.5 webcomicsapp 10.1 Schrödinger 10.0 chinabsc 9.9 hyperstrong 9.7 alamarbio 9.6 clounix 9.6 beva 1 API 9.5 houmo 9.2 WeRide 9.2 Zhihu 9.2 domob 9.1 geneditbio 9.0 matwings 9.0 sanegenebio 9.0 xiudan 9.0 clinflash 8.7 contentbox 8.7 kktv5 8.7 xiaoyi 8.7 biolink 8.6 dmedglobal 8.6 birentech 8.5 infly 8.5 morewis 8.5 cubenergy 8.4 honess 8.4 ilovewoof 8.4 meetfuture 8.4 berrygenomics 8.3 canbridgepharma 8.3 sceneray 8.3 xellsmart 8.3 letel 8.2 tingsn 8.1 clearorthod 8.0 yesmro 8.0 bioyond 7.9 completeomics 7.9 d 7.9 vancl 7.7 convenientpower 7.6 tongdun 7.6 Bilibili 7.5 Meituan 7.5 joesfuturefood 7.4 alphabiopharma 7.3 aptmed 7.2 photoncrystal 7.0 koalareading 6.9 liangyihui 6.9 vistel 6.9 wx-visionpro 6.9 igetget 6.7 biotree 6.5 bondent 6.5 curegenetics 6.5 inscinstech 6.5 nurotron 6.5 shinehe 6.5 atom-semiconductor 6.3 axera-tech 6.3 cixtech 6.3 emergen 6.3 finern 6.3 inventisbio 6.3 venusmedtech 6.3 aeonmed 6.1 cutt 6.1 docin 6.1 hxgroup 6.1 Insilico Medicine 6.1 kuwo 6.1 petkit 6.1 vrmedical 6.0 fimi 5.9 forgame 5.9 kintep 5.9 mk-semi 5.9 1yongcloud 5.7 arkbiosciences 5.7 bjgoodwill 5.7 bouffalolab 5.7 insight-med 5.7 m20genomics 5.7 singularmedical 5.7 veer 5.7 xiaomishu 5.7 leapstack 5.6 yuanbaobaoxian 5.6 yuanxinjituan 5.6 ylhyoil 5.5 abbisko 5.4 aceabio 5.4 aceatherapeutics 5.4 acxel 5.4 ai-prime 5.4 aistarfish 5.4 arrailgroup 5.4 atantares 5.4 bayomics 5.4 besunyen 5.4 cansinotech 5.4 centreherbs 5.4 cmlabs 5.4 colandpharma 5.4 csr-biotech 5.4 dezhentech 5.4 dkmedtech 5.4 firstgrid 5.4 guahao 5.4 guokang 5.4 healthgenetech 5.4 huimei 5.4 innostic 5.4 jacobiopharma 5.4 jfkbio 5.4 lih-invest 5.4 longwill 5.4 medmotion 5.4 medsci 5.4 medxtmc 5.4 novoprotein 5.4 prcxi 5.4 primelifescience 5.4 rdbio 5.4 sh-eco 5.4 shsongli 5.4 shukun 5.4 sinobiological 5.4 sinomdt 5.4 sinotau 5.4 sinovision-tech 5.4 snssurgical 5.4 suh 5.4 sunnydental 5.4 tisenc 5.4 tpmedical 5.4 tripod-glp 5.4 vinno 5.4 xiaoniaokuaiyan 5.4 zeenhealth 5.4 zhaohu365 5.4 quickpic 5.2 2duche 5.0 61draw 5.0 7k7k 5.0 afujingyou 5.0 airquality 5.0 aplum 5.0 appconomy 5.0 baoyugame 5.0 beijingyuanxin 5.0 black-unique 5.0 bomming 5.0 btrchina 5.0 budcreate 5.0 cashbus 5.0 cehome 5.0 cencorp 5.0 changeducation 5.0 chatail 5.0 china-fif 5.0 chushou 5.0 clubfactory 5.0 cn 5.0 coohua 5.0 cygia 5.0 dajiabao 5.0 deepway 5.0 dstzc 5.0 eigencomm 5.0 eigentech 5.0 fangtek 5.0 fanli 5.0 galbot 5.0 gohoo 5.0 gyenno 5.0 hanqigroup 5.0 haoyiku 5.0 hortorgames 5.0 iceonline 5.0 idsmanager 5.0 iqi-inc 5.0 jiayuan 5.0 jsgaiya 5.0 juren 5.0 kaiheikeji 5.0 kaixin001 5.0 kechowpharma 5.0 liangzizhige 5.0 lupuamc 5.0 mafengwo 5.0 micropointbio 5.0 mobike 5.0 mogujie 5.0 moretickets 5.0 mucho 5.0 muttoinc 5.0 nasn-auto 5.0 nvxclouds 5.0 oneasp 5.0 pps 5.0 prismlab 5.0 prmeasure 5.0 reddoorz 5.0 reetian 5.0 roxmotor 5.0 ruhnn 5.0 sinocelltech 5.0 speschina 5.0 supermag 5.0 t4game 5.0 thorough 5.0 trytrytw 5.0 tuhu 5.0 tujia 5.0 ypxfood 5.0 yunjichina 5.0 yunyinggu 5.0 bioscience-tj 4.3 cdhot 4.3 coremed 4.3 desano 4.3 gammastar 4.3 gaugene 4.3 immune-path 4.3 inbilin 4.3 justmedical 4.3 longbio 4.3 marvel-tech 4.3 medicaldl 4.3 novamab 4.3 novast 4.3 oricell 4.3 rensenergy 4.3 shulanhealth 4.3 tellgen 4.3 wecare-bio 4.3 miwuyy 4.1 bbi-lifesciences 3.8 61 3.2 abcfintech 3.2 abupdate 3.2 alltechmed 3.2 anxinyisheng 3.2 aohua 3.2 broncus 3.2 cdthchem 3.2 ceta 3.2 china-richen 3.2 chubao 3.2 chuhang 3.2 chumanapp 3.2 citic-pharm 3.2 corp 3.2 dinovamedtech 3.2 frontis 3.2 genorbio 3.2 glightmed 3.2 hypereal 3.2 itiangua 3.2 ivder 3.2 jcxj 3.2 jhtcm 3.2 jinkongauto 3.2 keysino 3.2 lpamina 3.2 luotianyi 3.2 miaoshou 3.2 mitralign 3.2 neiwai 3.2 nurien 3.2 oceg 3.2 one-chip 3.2 pelliot 3.2 pluslife 3.2 qiangsenmedical 3.2 sanyoumed 3.2 sgeet 3.2 shanzhen 3.2 shenogen 3.2 shiyunji 3.2 sieredu 3.2 sweetome 3.2 t 3.2 tasogare 3.2 thinktrans 3.2 tongzhuogame 3.2 vlightv 3.2 wowjoy 3.2 woxiaoya 3.2 xbonline 3.2 yoaa 3.2 zchb-water 3.2 zd-med 3.2 zhaosuliao 3.2 zhixiaole 3.2 zjbanger 3.2 zuoshouyisheng 3.2 zuzuche 3.2

Properties

Portfolio

Where the firm publishes its investments

Team

Partners and investing staff

Content

Blog, podcast, newsletter, and research

Firm

The firm itself

Other

Everything else declared in apis.yml

Source (apis.yml)

apis.yml Raw ↑
aid: qiming
name: Qiming Venture Partners
description: >-
  Qiming Venture Partners is a leading China-based venture capital firm founded in 2006 by Duane Kuang
  and Gary Rieschel, headquartered in Shanghai with additional offices in Beijing, Suzhou, Hong Kong,
  Singapore, and a U.S. affiliate (Qiming Venture Partners USA) in Seattle, Washington. The firm invests
  at the early and growth stages, with roughly 70% of its investments concentrated in Series A and Series B
  rounds, across two core practice areas: Technology (mobile internet, consumer, AI, robotics,
  semiconductors, enterprise software, autonomous driving) and Healthcare (biotech, pharmaceuticals,
  medical devices, diagnostics, and digital health). Qiming manages 11 U.S. Dollar funds and 7 RMB funds
  with approximately $9.5 billion in capital raised, and has backed more than 580 companies, of which over
  210 have exited via IPO on the NYSE, NASDAQ, HKEX, Shanghai, or Shenzhen exchanges, or through M&A. It is
  an early backer of some of China's most influential technology companies, including Xiaomi, Meituan,
  Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, Insta360, and Zhipu AI (Z.ai), alongside a
  deep healthcare portfolio spanning Zai Lab, Gan & Lee Pharmaceuticals, CanSino Biologics, Tigermed, and
  Insilico Medicine.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.qimingvc.com/favicon.ico
x-type: venture-capital
x-category: Venture Capital
created: '2026-07-17'
modified: '2026-07-17'
specificationVersion: '0.20'
tags:
  - Venture Capital
  - Seed
  - Series A
  - Series B
  - Growth Equity
  - Technology
  - Healthcare
  - Artificial Intelligence
  - Semiconductors
  - Robotics
  - Biotech
  - China
  - Asia
apis: []
common:
  - type: Website
    url: https://www.qimingvc.com/en
  - type: Portfolio
    url: https://www.qimingvc.com/en/portfolio
  - type: Portfolio
    url: portfolio/qiming-portfolio.yml
  - type: Team
    url: https://www.qimingvc.com/en/team
  - type: Team
    url: team/qiming-team.yml
  - type: InvestmentThesis
    url: https://www.qimingvc.com/en/about
  - type: News
    url: https://www.qimingvc.com/en/newsroom
  - type: Jobs
    url: https://www.qimingvc.com/en/careers
  - type: Pitch
    url: mailto:BP@qimingvc.com
  - type: Contact
    url: mailto:contactus@qimingvc.com
  - type: Crunchbase
    url: https://www.crunchbase.com/organization/qiming-venture-partners
  - type: LinkedIn
    url: https://www.linkedin.com/company/qiming-venture-partners
  - type: Twitter
    url: https://twitter.com/QimingVC
  - type: Features
    data:
      - "Stage: Early and growth stage; ~70% in Series A / Series B"
      - "Sectors: Technology (mobile internet, consumer, AI, robotics, semiconductors, enterprise software, autonomous driving) and Healthcare (biotech, pharmaceuticals, medical devices, diagnostics, digital health)"
      - "Geography: Greater China, with a U.S. affiliate in Seattle"
      - "Capital raised: ~$9.5B across 11 USD funds and 7 RMB funds"
      - "Portfolio: 580+ companies, 210+ IPO exits"
      - "Founded: 2006"
      - "HQ: Shanghai, China (offices in Beijing, Suzhou, Hong Kong, Singapore, Seattle)"
    sources:
      - https://www.qimingvc.com/en/about
      - https://en.wikipedia.org/wiki/Qiming_Venture_Partners
    updated: '2026-07-17'
maintainers:
  - FN: Kin Lane
    email: info@apievangelist.com
    url: https://apievangelist.com
  - FN: APIs.json
    url: http://apisjson.org
  - FN: Qiming Venture Partners
    url: https://www.qimingvc.com/en